Adagio initiates global phase II/III EVADE study of ADG-20 for the prevention of COVID-19 May 6, 2021
AbCellera and Eli Lilly present second antibody to enter clinical development against COVID-19 May 6, 2021
First healthy volunteers dosed in phase I/II study of HDT Bio's COVID-19 RNA vaccine in India May 5, 2021
Synairgen reports home cohort and combined analysis from phase II trial of SNG-001 in COVID-19 May 3, 2021
RSS